–
Calidi Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
−13.2
FY23:
−27.0
FY24:
−19.7
FY25:
−21.3
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−0.49
FY23:
−0.48
FY24:
−0.02
FY25:
−0.17
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
12.1
FY23:
29.0
FY24:
27.4
FY25:
17.5
millions USD
FY21:
–
FY22:
−0.97
FY23:
1.58
FY24:
7.64
FY25:
−3.99
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.98
FY22:
−13.6
FY23:
−27.6
FY24:
−19.7
FY25:
−21.4
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.